virus video.png
IMG_3136.JPG
virus video.png

About


We Discover Cures & Transform Lives

Developing highly selective therapeutics to target human disease.

SCROLL DOWN

About


We Discover Cures & Transform Lives

Developing highly selective therapeutics to target human disease.

About

Riboscience applies specialized chemistry and biology to create novel treatments for human diseases. We particularly focus on building ribose-based molecules and we use structure-guided design to generate highly selective and efficacious drug candidates.

Nucleoside analogs are examples of ribose-based molecules that have become important drugs for the treatment of a number of viral diseases and cancers.  The Riboscience library of nucleoside and non-nucleoside molecules is rationally designed to deliver drug candidates that are highly efficacious and highly selective for essential targets in the virology and oncology spaces.

IMG_3136.JPG

Management


Management

Management


Management

The Riboscience leadership team has over 50 years of combined expertise that spans the research and development spectrum, from drug discovery and development to drug approval, and beyond.

Klaus Klumpp   Founder and President

Klaus Klumpp

Founder and President

Jeffrey Glenn   Founder, Virology and Strategy 

Jeffrey Glenn

Founder, Virology and Strategy 

Mark Smith   Founder and Head of Chemistry

Mark Smith

Founder and Head of Chemistry

Peter Crnkovich   Financial and Strategic Advisor

Peter Crnkovich

Financial and Strategic Advisor

 
 

Investors


Investors

Investors


Investors

Riboscience is funded by a consortium of specialist investors experienced with biotechnology.

 

Join us


Join us